Skip to content
Home/Companies/HealthTech/Antidote

Antidote

HealthTech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Antidote?

Antidote is a British HealthTech company, currently owned by LBO France since 2025.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
LBO France
Investor
LBO France
LBO France Venture · 2016 · VC

Key facts

HQUK
SectorHealthTech

More from LBO France Venture

Other portfolio companies in the same fund.

12.5
Active
TMTFrance· 2025
Mediaire
Active
HealthTechGermany· 2025
Siteflow
Siteflow
Active
SaaSFrance· 2025
Colpad
Active
HealthcareFrance· 2024
Vestalis
Vestalis
Active
ConsumerFrance· 2023
Diabeloop
Diabeloop
Active
MedTechFrance· 2022

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Antidote?

Antidote is currently owned by LBO France, through LBO France Venture, since 2025.

When did LBO France acquire Antidote?

LBO France acquired Antidote in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue